Timothy Wright
2017 - Regulus Therapeutics
In 2017, Timothy Wright earned a total compensation of $1.2M as Chief Research & Development Officer at Regulus Therapeutics, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $134,196 |
|---|---|
| Option Awards | $596,145 |
| Salary | $453,366 |
| Other | $5,350 |
| Total | $1,189,057 |
Wright received $596.1K in option awards, accounting for 50% of the total pay in 2017.
Wright also received $134.2K in non-equity incentive plan, $453.4K in salary and $5.4K in other compensation.
Rankings
In 2017, Timothy Wright's compensation ranked 8,144th out of 14,666 executives tracked by ExecPay. In other words, Wright earned more than 44.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,144 out of 14,666 | 45th |
Division Manufacturing | 3,071 out of 5,772 | 47th |
Major group Chemicals And Allied Products | 1,015 out of 2,075 | 51st |
Industry group Drugs | 798 out of 1,731 | 54th |
Industry Pharmaceutical Preparations | 627 out of 1,333 | 53rd |
Source: SEC filing on April 20, 2018.
Wright's colleagues
We found four more compensation records of executives who worked with Timothy Wright at Regulus Therapeutics in 2017.
News
Century Casinos CEO Peter Hoetzinger's 2021 pay jumps 27% to $1.4M
April 28, 2022
Century Casinos CEO Peter Hoetzinger's 2020 pay falls 23% to $1.1M
April 30, 2021
Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
July 1, 2019
Century Casinos CEO Erwin Haitzmann's 2018 pay rises 3% to $1.4M
April 30, 2019